IgE-tailpiece associates with α-1-antitrypsin (A1AT) to protect IgE from proteolysis without compromising its ability to interact with FcεRI

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Quinn, Phyllis M ^a   Dunne, David W ^b   Moore, Shona C ^c,d   Pleass, Richard J ^c  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^d UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E RECEPTOR; ISOPROTEIN;

CHEMISTRY; HELMINTHIASIS; HUMAN; IMMUNOLOGY; METABOLISM; PROTEIN DEGRADATION;

ALPHA 1-ANTITRYPSIN; HELMINTHIASIS; HUMANS; IMMUNOGLOBULIN E; PROTEIN ISOFORMS; PROTEOLYSIS; RECEPTORS, IGE;

EID: 84957580551     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep20509     Document Type: Article

References (77)

1. Gould, H. J. & Sutton, B. J. IgE in allergy and asthma today. Nat. Rev. Immunol. 8, 205-217 (2008).
2. Galli, S. J. & Tsai, M. IgE and mast cells in allergic disease. Nature Medicine 18, 693-704 (2012).
3. Kinet, J. P. The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology. Annu. Rev. Immunol. 17, 931-972 (1999).
4. Novak, N. et al. Fcaε RI engagement of Langerhans cell-like dendritic cells and inflammatory dendritic epidermal cell-like dendritic cells induces chemotactic signals and different T-cell phenotypes in vitro. J. Allergy Clin. Immunol. 113, 949-957 (2004).
5. Platzer, B. et al. Dendritic cell-bound IgE functions to restrain allergic inflammation at mucosal sites. Mucosal Immunol. 8, 516-532 (2014).
6. Platzer, B., Stout, M. & Fiebiger, E. Functions of dendritic-cell-bound IgE in allergy. Mol. Immunol. doi: http://dx.doi.org/10.1016/j.molimm.2015.05.016
7. Baravalle, G., Greer, A. M., Laflam, T. N. & Shin, J.-S. Antigen-Conjugated Human IgE Induces Antigen-Specific T Cell Tolerance in a Humanized Mouse Model. J. Immunol. 192, 3280-8 (2014).
8. Greer, A. M. et al. Serum IgE clearance is facilitated by human FcepsilonRI internalization. J. Clin. Invest. 124, 1187-1198 (2014).
9. Chan, L. A., Lyczak, J. B., Zhang, K., Morrison, S. L. & Saxon, A. The novel human IgE epsilon heavy chain, epsilon tailpiece, is present in plasma as part of a covalent complex. Mol. Immunol. 37, 241-252 (2000).
10. Zhang, K., Saxon, A. & Max, E. E. Two unusual forms of human immunoglobulin E encoded by alternative RNA splicing of epsilon heavy chain membrane exons. J. Exp. Med. 176, 233-243 (1992).
11. Zhang, K., Max, E. E., Cheah, H. K. & Saxon, A. Complex alternative RNA splicing of ε-immunoglobulin transcripts produces mRNAs encoding four potential secreted protein isoforms. J. Biol. Chem. 269, 456-462 (1994).
12. Diaz-Sanchez, D., Zhang, K., Nutman, T. B. & Saxon, A. Differential regulation of alternative 3′ splicing of epsilon messenger RNA variants. J. Immunol. 155, 1930-1941 (1995).
13. Batista, F. D., Efremov, D. G. & Burrone, O. R. Characterization of a second secreted IgE isoform and identification of an asymmetric pathway of IgE assembly. Proc. Natl. Acad. Sci. USA 93, 3399-3404 (1996).
14. Lorenzi, R., Jouvin, M. H. & Burrone, O. R. Functional Fc epsilonRI engagement by a second secretory IgE isoform detected in humans. Eur. J. Immunol. 29, 936-945 (1999).
15. Lyczak, J. B., Zhang, K., Saxon, A. & Morrison, S. L. Expression of novel secreted isoforms of human immunoglobulin E proteins. J. Biol. Chem. 271, 3428-3436 (1996).
16. MacDonald, S. M., Langdon, J. M., Greenlee, B. M., Kagey-Sobotka, A. & Lichtenstein, L. M. IgE-dependent histamine-releasing factors. A brief review. Int. Arch. Allergy Appl. Immunol. 94, 144-147 (1991).
17. Saxon, A., Kurbe-Leamer, M., Behle, K., Max, E. E. & Zhang, K. Inhibition of human IgE production via Fc epsilon R-II stimulation results from a decrease in the mRNA for secreted but not membrane epsilon H chains. J. Immunol. 147, 4000-4006 (1991).
18. Aslam, A., Lewis, R. J., Wheatley, A., Pleass, R. J. & Sayers, I. The secretory tailpiece isoform of IgE is not associated with allergy. Allergy 63, 942-3 (2008).
19. Hagan, P., Blumenthal, U. J., Dunn, D., Simpson, A. J. & Wilkins, H. A. Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature 349, 243-245 (1991).
20. Dunne, D. W. et al. Immunity after treatment of human schistosomiasis: Association between IgE antibodies to adult worm antigens and resistance to reinfection. Eur. J. Immunol. 22, 1483-1494 (1992).
21. Gounni, A. S. et al. High-affinity IgE receptor on eosinophils is involved in defence against parasites. Nature 367, 183-186 (1994).
22. Craig, J. M. & Scott, A. L. Helminths in the lungs. Parasite Immunol. 36, 463-474 (2014).
23. Anthony, R. M., Rutitzky, L. I., Urban Jr., J. F., Stadecker, M. J. & Gause, W. C. Protective immune mechanisms in helminth infection. Nat Rev Immunol 7, 975-987 (2007).
24. Marsland, B. J., Kurrer, M., Reissmann, R., Harris, N. L. & Kopf, M. Nippostrongylus brasiliensis infection leads to the development of emphysema associated with the induction of alternatively activated macrophages. Eur. J. Immunol. 38, 479-488 (2008).
25. Pleass, R. J., Kusel, J. R. & Woof, J. M. Cleavage of human IgE mediated by Schistosoma mansoni. Int. Arch. Allergy Immunol. 121, 194-204 (2000).
26. Aslam, A. et al. Proteases from Schistosoma mansoni cercariae cleave IgE at solvent exposed interdomain regions. Mol. Immunol. 45, 567-74 (2008).
27. Dunne, D. W. et al. Applied and basic research on the epidemiology, morbidity, and immunology of schistosomiasis in fishing communities on Lake Albert, Uganda. Trans. R. Soc. Trop. Med. Hyg. 100, 216-223 (2006).
28. Laurell, C. B. & Thulin, E. Complexes in plasma between light chain kappa immunoglobulins and alpha 1-antitrypsin respectively prealbumin. Immunochemistry 11, 703-709 (1974).
29. Scott, L. J., Evans, E. L., Dawes, P. T., Russell, G. I. & Mattey, D. L. Comparison of IgA-alpha1-antitrypsin levels in rheumatoid arthritis and seronegative oligoarthritis: complex formation is not associated with inflammation per se. Br. J. Rheumatol. 37, 398-404 (1998).
30. Behrens, M. A. et al. The Shapes of Z-α1-Antitrypsin Polymers in Solution Support the C-Terminal Domain-Swap Mechanism of Polymerization. Biophys. J. 107, 1905-1912 (2014).
31. Yamasaki, M., Li, W., Johnson, D. J. D. & Huntington, J. A. Crystal structure of a stable dimer reveals the molecular basis of serpin polymerization. Nature 455, 1255-1258 (2008).
32. Yamasaki, M., Sendall, T. J., Pearce, M. C., Whisstock, J. C. & Huntington, J. A. Molecular basis of α1-antitrypsin deficiency revealed by the structure of a domain-swapped trimer. EMBO reports 12, 1011-1017 (2011).
33. Vaerman, J. P., Hagiwara, K., Kobayashi, K. & Rits, M. Complexes of albumin and alpha 1-antitrypsin with Fc-fragment of IgA monomer are disulfide-bound to penultimate C-terminal cysteine in the C alpha 3-domain. Immunol. Lett. 15, 67-72 (1987).
34. Janciauskiene, S., Dominaitiene, R., Sternby, N. H., Piitulainen, E. & Eriksson, S. Detection of circulating and endothelial cell polymers of Z and wild type alpha 1-antitrypsin by a monoclonal antibody. J. Biol. Chem. 277, 26540-26546 (2002).
35. De Serres, F. & Blanco, I. Role of alpha-1-antitrypsin in human health and disease. J. Intern. Med. 276, 311-335 (2014).
36. Lomas, D. A., Evans, D. L., Finch, J. T. & Carrell, R. W. The mechanism of Z alpha 1-antitrypsin accumulation in the liver. Nature 357, 605-607 (1992).
37. Boudier, C. & Bieth, J. G. The reaction of serpins with proteinases involves important enthalpy changes. Biochemistry 40, 9962-9967 (2001).
38. Gettins, P. G. W. Serpin structure, mechanism, and function. Chem. Rev. 102, 4751-4803 (2002).
39. Lomas, D. A., Evans, D. L., Stone, S. R., Chang, W. S. & Carrell, R. W. Effect of the Z mutation on the physical and inhibitory properties of alpha 1-antitrypsin. Biochemistry 32, 500-508 (1993).
40. Belorgey, D., Crowther, D. C., Mahadeva, R. & Lomas, D. A. Mutant neuroserpin (S49P) that causes familial encephalopathy with neuroserpin inclusion bodies is a poor proteinase inhibitor and readily forms polymers in vitro. J. Biol. Chem. 277, 17367-17373 (2002).
41. Mast, A. E., Enghild, J. J. & Salvesen, G. Conformation of the reactive site loop of alpha 1-proteinase inhibitor probed by limited proteolysis. Biochemistry 31, 2720-2728 (1992).
42. Boswell, D. R., Jeppsson, J. O., Brennan, S. O. & Carrell, R. W. The reactive site of alpha 1-antitrypsin is C-terminal, not N-terminal. Biochim. Biophys. Acta 744, 212-218 (1983).
43. Maurer, D. et al. Expression of functional high affinity immunoglobulin E receptors (Fc epsilon RI) on monocytes of atopic individuals. J. Exp. Med. 179, 745-750 (1994).
44. Lewis, M. J., Pleass, R. J., Batten, M. R., Atkin, J. D. & Woof, J. M. Structural requirements for the interaction of human IgA with the human polymeric Ig receptor. J. Immunol. 175, 6694-701 (2005).
45. Atkin, J. D., Pleass, R. J., Owens, R. J. & Woof, J. M. Mutagenesis of the human IgA1 heavy chain tailpiece that prevents dimer assembly. J. Immunol. 157, 156-9 (1996).
46. Struthers, G. R., Lewin, I. V. & Stanworth, D. R. IgA-alpha 1 antitrypsin complexes in ankylosing spondylitis. Ann. Rheum. Dis. 48, 30-34 (1989).
47. Zhou, A. & Carrell, R. W. Dimers Initiate and Propagate Serine Protease Inhibitor Polymerisation. J. Mol. Biol. 375, 36-42 (2008).
48. Talens, S., Malfliet, J. J. M. C., van Hal, P. T. W., Leebeek, F. W. G. & Rijken, D. C. Identification and characterization of α1-antitrypsin in fibrin clots. J. Thromb. Haemost. 11, 1319-28 (2013).
49. Lomas, D. A. Twenty years of polymers: a personal perspective on alpha-1 antitrypsin deficiency. COPD 10 Suppl 1, 17-25 (2013).
50. Dafforn, T. R., Mahadeva, R., Elliott, P. R., Sivasothy, P. & Lomas, D. A. A kinetic mechanism for the polymerization of alpha1-antitrypsin. J. Biol. Chem. 274, 9548-9555 (1999).
51. Thandapani, P., O'Connor, T. R., Bailey, T. L. & Richard, S. Defining the RGG/RG Motif. Mol. Cell 50, 613-623 (2013).
52. Lomas, D. A. The selective advantage of alpha-1-antitrypsin deficiency. Am. J. Respir. Crit. Care Med. 173, 1072-1077 (2006).
53. Blanco, I., Fernández, E. & Bustillo, E. F. Alpha-1-antitrypsin PI phenotypes S and Z in Europe: an analysis of the published surveys. Clin. Genet. 60, 31-41 (2001).
54. Søe, M. J., Nejsum, P., Fredensborg, B. L. & Kapel, C. M. O. DNA Typing of Ancient Parasite Eggs from Environmental Samples Identifies Human and Animal Worm Infections in Viking-Age Settlement. J. Parasitol. 101, 57-63 (2015).
55. Malerba, M. et al. Neutrophilic inflammation and IL-8 levels in induced sputum of alpha-1-antitrypsin PiMZ subjects. Thorax 61, 129-133 (2006).
56. Wright, V. & Bickle, Q. Immune responses following experimental human hookworm infection. Clin. Exp. Immunol. 142, 398-403 (2005).
57. Modha, J. & Doenhoff, M. J. Complex formation of human alpha-1-antitrypsin with components in Schistosoma mansoni cercariae. Parasite Immunol. 16, 447-450 (1994).
58. Truden, J. L. & Boros, D. L. Detection of alpha 2-macroglobulin, alpha 1-protease inhibitor, and neutral protease-antiprotease complexes within liver granulomas of Schistosoma mansoni-infected mice. Am. J. Pathol. 130, 281-288 (1988).
59. Loffredo-Verde, E. et al. Schistosome infection aggravates HCV-related liver disease and induces changes in the regulatory T-cell phenotype. Parasite Immunol. 37, 97-104 (2015).
60. Ray, D. et al. Acquired alpha 1-antitrypsin deficiency in tropical pulmonary eosinophilia. Indian J. Med. Res. 134, 79-82 (2011).
61. Ray, D. & Krishna, K. S. Alpha1-antitrypsin in tropical pulmonary eosinophilia. Chest 104, 487-492 (1993).
62. Huntington, J. A., Read, R. J. & Carrell, R. W. Structure of a serpin-protease complex shows inhibition by deformation. Nature 407, 923-926 (2000).
63. Johnson, D. & Travis, J. Structural evidence for methionine at the reactive site of human alpha-1-proteinase inhibitor. J. Biol. Chem. 253, 7142-7144 (1978).
64. Herz, J. & Strickland, D. K. LRP: A multifunctional scavenger and signaling receptor. J. Clin. Invest. 108, 779-784 (2001).
65. Strickland, D. K., Au, D. T., Cunfer, P. & Muratoglu, S. C. Low-density lipoprotein receptor-related protein-1: Role in the regulation of vascular integrity. Arterioscler. Thromb. Vasc. Biol. 34, 487-498 (2014).
66. Yu, L., Cao, G., Repa, J. & Stangl, H. Sterol regulation of scavenger receptor class B type I in macrophages. J. Lipid Res. 45, 889-899 (2004).
67. Svensson, P.-A. et al. Regulation and splicing of scavenger receptor class B type I in human macrophages and atherosclerotic plaques. BMC Cardiovasc. Disord. 5, 25 (2005).
68. Goldstein, J. L., Ho, Y. K., Basu, S. K. & Brown, M. S. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl. Acad. Sci. USA 76, 333-337 (1979).
69. Kalsheker, N. a. alpha1-Antitrypsin deficiency: best clinical practice. J. Clin. Pathol. 62, 865-869 (2009).
70. Dreskin, S. C., Goldsmith, P. K., Strober, W., Zech, L. A. & Gallin, J. I. Metabolism of immunoglobulin E in patients with markedly elevated serum immunoglobulin E levels. J. Clin. Invest. 79, 1764-1772 (1987).
71. Lusch, A. et al. Development and analysis of alpha 1-antitrypsin neoglycoproteins: The impact of additional N-glycosylation sites on serum half-life. Mol. Pharm. 10, 2616-2629 (2013).
72. Joseph, M. et al. Expression and functions of the high-affinity IgE receptor on human platelets and megakaryocyte precursors. Eur. J. Immunol. 27, 2212-2218 (1997).
73. Sun, Y. et al. A Human Platelet Receptor Protein Microarray Identifies the High Affinity Immunoglobulin E Receptor Subunit α (FcεR1α) as an Activating Platelet Endothelium Aggregation Receptor 1 (PEAR1) Ligand. Mol. Cell. Proteomics 14, 1265-1274 (2015).
74. Ali, A. Assessing the association between omalizumab and arteriothrombotic events through spontaneous adverse event reporting. J. Asthma Allergy 5, 1-9 (2012).
75. Janciauskiene, S. M. et al. The discovery of α1-antitrypsin and its role in health and disease. Respiratory Medicine 105, 1129-1139 (2011).
76. Adame-Gallegos, J. R., Shi, J., McIntosh, R. S. & Pleass, R. J. The generation and evaluation of two panels of epitope-matched mouse IgG1, IgG2a, IgG2b and IgG3 antibodies specific for Plasmodium falciparum and Plasmodium yoelii merozoite surface protein 1-19 (MSP1(19)). Exp. Parasitol. 130, 384-93 (2012).
77. Kabatereine, N. B. et al. Adult resistance to schistosomiasis mansoni: age-dependence of reinfection remains constant in communities with diverse exposure patterns. Parasitology 118 (Pt 1), 101-105 (1999).